Structural Localization of Mass-Degenerate Intact tRNA <sup>PHE</sup> Species by Ion-Pair UHPLC–HRMS and CID–MS <sup>3</sup>
Intact mass spectrometry of structured RNAs preserves full-length molecular context but is intrinsically susceptible to mass degeneracy arising from single-methyl variations and biosynthetic intermediates. Neutral mass measurements alone are insufficient for unambiguous structural assignment. Here, we demonstrate a structured analytical strategy integrating ion-pair UHPLC–high-resolution mass spectrometry (IP-UHPLC–HRMS), nucleoside-level HCD confirmation, and CID–MS 3 structural localization to resolve mass-degenerate species in yeast tRNA PHE . Intact profiling of wild-type (WT) and ΔTYW3 strains revealed a reproducible −14 Da subpopulation that was indistinguishable at the neutral-mass level. CID–MS 3 of the base-loss fragment established backbone identity, while UVPD preserved a precursor m / z shift consistent with a 14 Da neutral mass difference localized to the wybutosine (yW) modification. These orthogonal measurements localized the -14 Da difference without reliance on database-only assignments or fragment-level inference. The approach is illustrated using the yW pathway as a defined test case for resolving intact RNA mass degeneracy.
Authors
- Keeley Murphy
- Robert Ross (ORCID: https://orcid.org/0000-0001-8710-3675)
- Markus Bursch (ORCID: https://orcid.org/0000-0001-6711-5804)
- Roberto Gamez
- Hangyan Sun
- Tsutomu Suzuki
- Min Du
- Bernardo de Souza
Institutions
- Research Institute for Chromatography (BE)
- IONICS Mass Spectrometry (Canada) (CA)
- Thermo Fisher Scientific (United States) (US)
- The University of Tokyo (JP)
Publication Details
- Journal
- Analytical Chemistry
- Published
- 2026-06-18
- DOI
- https://doi.org/10.1021/acs.analchem.6c01855
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00